NCT00360230 Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children Status COMPLETED Phase PHASE2
NCT00360126 An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder Status COMPLETED Phase PHASE4
NCT00359983 Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB Status COMPLETED Phase PHASE3
NCT00359619 Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine Status COMPLETED Phase PHASE2
NCT00359463 Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment Status COMPLETED Phase PHASE1
NCT00359190 Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer Status COMPLETED Phase PHASE1
NCT00359177 Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT00359112 AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00358813 Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment Status COMPLETED Phase PHASE1
NCT00358540 Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide Status COMPLETED Phase PHASE1
NCT00358488 Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients Status COMPLETED Phase PHASE2
NCT00358449 Intravenous Mepolizumab In Children With Eosinophilic Esophagitis Status COMPLETED Phase PHASE2
NCT00358410 An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia Status COMPLETED Phase PHASE2
NCT00358384 Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 Status COMPLETED Phase PHASE1
NCT00358371 Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) Status COMPLETED Phase PHASE1
NCT00357097 The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome Status COMPLETED Phase PHASE3
NCT00357045 Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine Status COMPLETED Phase PHASE4